Health Care/Hospital

Wonder Tech's Breakthrough in Language Agnostic Voice AI to Bring Scalable Depression Screening to One Billion People Globally

SINGAPORE, Nov. 28, 2023 /PRNewswire/ -- Wonder Technologies PTE. LTD ("Wonder Tech" or "the Company"), a leading AI-driven mental health solutions company based inSingapore, has reached a breakthrough in its acoustics-based AI for depression screening. The AI model, which identifies depression t...

2023-11-29 00:00 1766

Rhino Rescue Expands Horizons at Medica 2023, Exploring New Opportunities in the European Market

DÜSSELDORF, Germany, Nov. 28, 2023 /PRNewswire/ -- Rhino Rescue made a strong appearance at Medica inGermany, showcasing the comprehensive range of its latest technologies and products. During the event, more than 20 companies expressed their intention to partner with Rhino Rescue, thereby expand...

2023-11-28 23:00 1466

Dr. Liu Jian, President of Medicilon Drug Discovery Division, wins the Thomas Alva Edison Patent Award

BOSTON, Nov. 28, 2023 /PRNewswire/ -- Dr. Liu Jian, President of the Drug Discovery Division at Medicilon, has been awarded the Thomas Alva Edison Patent Award for 2023 from the New Jersey Research and Development Committee. This recognition stems from his innovative patent on the PCSK9 inhibitor...

2023-11-28 21:30 1312

Akeso Launches Construction of Shanghai Global R&D Center to Accelerate Its Innovation Globalization Strategy

HONG KONG, Nov. 28, 2023 /PRNewswire/ -- The groundbreaking ceremony for Akeso (9926.HK)  Shanghai Global R&D Center was successfully held at the Zhangjiang headquarters park inShanghai. The establishment of the Akeso Global R&D Center signifies a crucial step in Akeso's innovative globalization ...

2023-11-28 21:00 2164

PAAMC HK Wins ESG Investing Award for Three Consecutive Years

HONG KONG, Nov. 28, 2023 /PRNewswire/ -- Ping An of China Asset Management ( Hong Kong) Company Limited ("PAAMC HK" or "Company"), the offshore asset management arm of the Ping An Insurance (Group) Company ofChina, Ltd. ("Ping An "), was bestowed the ESG Leading Enterprises Awards 2023, recognized ...

2023-11-28 15:48 1460

USANA Malaysia Executive Honored by The Asian Business Review

Vivienne Lee Awarded Executive of the Year KUALA LUMPUR, Malaysia, Nov. 28, 2023 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in nutrition, is excited to congratulateVivienne Lee, Regional Vice President ofMalaysia, Singapore, Hong Kong, Indonesia, and Taiwan . She was recently n...

2023-11-28 09:57 1326

AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology

* AI-powered spatial analysis of tumor-infiltrating lymphocytes using Lunit SCOPE IO provides accurate prognosis prediction in stage II–III colon cancer SEOUL, South Korea, Nov. 27, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and...

2023-11-27 22:05 1474

Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Met Primary Endpoint of Progression-Free Survival in Phase III Trial for First-Line Treatment of Recurrent/Metastatic Cervical Cancer in All-Comer Patients

HONG KONG, Nov. 27, 2023 /PRNewswire/ -- Akeso (9926. HK) has announced that the AK104-303 Phase III trial, which investigated cadonilimab (Akeso's PD-1/CTLA-4 bispecific antibody) combined with platinum-based chemotherapy +/- bevacizumab, has met one of its primary endpoints of progression-fre...

2023-11-27 21:30 1451

Ascentage Pharma Hosts Ceremony Marking the Launch of Olverembatinib in Newly Approved Indication and the Dispatch of First Batch for the New Indication

SUZHOU, China, and ROCKVILLE, Md., Nov. 24, 2023 /PRNewswire/ -- 23 Nov, 2023, on the second anniversary of the initial approval for olverembatinib, Ascentage Pharma hosted a ceremony in Suzhou,China, marking the launch of olverembatinib in a newly approved indication and the dispatch of the firs...

2023-11-24 19:57 2307

China's First NDA for a KRAS G12C Inhibitor: NMPA Accepts New Drug Application for GFH925 and Grants GFH925 with Priority Review Designation

SHANGHAI, Nov. 24, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) ofChina has accepted the...

2023-11-24 19:00 2239

Neurophet to showcase brain image analysis technology at RSNA 2023

- Introducing Alzheimer's disease related brain image analysis technology including Neurophet AQUA and Neurophet SCALE PET - Plans to launch analysis technology for infant brain image and cerebrovascular disease SEOUL, South Korea, Nov. 23, 2023 /PRNewswire/ -- Neurophet, an artificial intellig...

2023-11-23 22:00 2043

Organic antibacterial preservative of ANDKWAN to protect both people and nature

* Evolution of Hygiene to Preserve the Earth SEOUL, South Korea, Nov. 22, 2023 /PRNewswire/ -- AndKwan Natural Science Inc. announced that it has succeeded in developing a new organic antibacterial preservative and an antibiotic composition containing it together with its parent company, White ...

2023-11-23 12:31 2096

PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome

* Study reveals a promising avenue for addressing Idiopathic Systemic Capillary Leak Syndrome (ISCLS, a.k.a. Clarkson Disease) and vessel-related rare disease indications * Unique Tie2-activating antibody program, PMC-403, demonstrates efficacy in improving survival and reducing vascular leak...

2023-11-23 10:31 1636

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology

- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accuracy is on par with that of radiologists in detecting breast cancer SEOUL, South Korea, Nov. 22, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diag...

2023-11-22 22:07 2082

United Imaging Intelligence to Unveil Cutting-edge AI Technology at RSNA

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- United Imaging Intelligence (UII), a pioneering subsidiary of United Imaging Group known for its innovative artificial intelligence (AI) applications in healthcare, is set to showcase its latest medical AI advancements at the upcoming Radiological Society o...

2023-11-22 22:00 1761

Waterdrop Inc. to Report Third Quarter 2023 Financial Results on December 7, 2023

BEIJING, Nov. 22, 2023 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH ) ("Waterdrop" or the "Company"), a leading technology platform d...

2023-11-22 19:00 3595

WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale

* By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture to final UF/DF pool at pilot scale * This end-to-end continuous bioprocess, which is in place for WuXi Biologics global manufacturing network, is...

2023-11-22 13:21 3600

Baird Medical Attains FDA Clearance to Market Its Microwave Ablation System in the United States

FRISCO, Texas, Nov. 21, 2023 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, today announced that its subsidiary, Betters (Suzhou) Medical Co., Ltd, has received clearance from the ...

2023-11-22 06:00 1668

United Imaging Showcases Pioneering Advances and Reinforces U.S. Growth at RSNA 2023

HOUSTON, Nov. 21, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is set to showcase its comprehensive portfolio of innovative technologies at RSNA 2023. This includes another series of global firsts and pioneering medical...

2023-11-21 14:57 1437

ST Pharm Presented '100-Day Expedite Strategy', Preparedness and Proactive Measures for Future Pandemic at Korea-CEPI R&D Workshop

SEOUL, South Korea, Nov. 20, 2023 /PRNewswire/ -- Nov. 21, 2023 local time, ST Pharm announced 'Rapid Preparedness of Pandemic Vaccine in 100 Days using ST Pharm's own mRNA Platform Technology' at the Korea-CEPI R&D Workshop in World Bio Summit 2023, organized by Korea Health Industry Development...

2023-11-21 12:00 1400
1 ... 60616263646566 ... 277

Week's Top Stories